Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers92

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers26

Views

Views
October 20255
November 20259
December 20254
January 20261
February 20260
March 20265
April 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United Kingdom2
Mexico2
United States2
Gabon2
Argentina1
Canada1
Congo1
Chile1
Algeria1
 

Top cities views

Views
Rio de Janeiro2
Libreville2
Algiers1
Ashburn1
Asunción1
Brazzaville1
Chihuahua City1
Curitiba1
Córdoba1
Dublin1